A comparison of efficiency and safety between dual and triple immunosuppressive regimens in pediatric living donor liver transplantation at King Chulalongkorn Memorial Hospital

Código QR

A comparison of efficiency and safety between dual and triple immunosuppressive regimens in pediatric living donor liver transplantation at King Chulalongkorn Memorial Hospital

Guardado en:

Detalles Bibliográficos
Autores principales:	Athaya Vorasittha, Methee Sutherasan, Wipusit Taesombat, Pongserath Sirichindakul, Supanit Nivatvong, Bunthoon Nonthasoot
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Liver transplantation Living donor Children Immunosuppressive agents Rejection Tacrolimus Surgery RD1-811
Acceso en línea:	https://doaj.org/article/4e498b8df76549fd96a2ccce2973b4f8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Retiro precoz de esteroides en la inmunosupresión del trasplante renal pediátrico
por: Delucchi B,Angela, et al.
Publicado: (2006)

Resultados a largo plazo en trasplante renal de donantes con criterios expandidos
por: Valjalo,Ricardo, et al.
Publicado: (2016)

Genetic Polymorphisms Affecting Tacrolimus Metabolism and the Relationship to Post-Transplant Outcomes in Kidney Transplant Recipients
por: Cheng F, et al.
Publicado: (2021)

Efficacy and Safety of Iguratimod Supplement to the Standard Immunosuppressive Regimen in Highly Mismatched Renal Transplant Recipients: A Pilot Study
por: Jun Tao, et al.
Publicado: (2021)

Spot Urine Protein Excretion in the First Year Following Kidney Transplantation Associates With Allograft Rejection Phenotype at 1-Year Surveillance Biopsies: An Observational National-Cohort Study
por: Manca Oblak, et al.
Publicado: (2021)

Safety, clinical and laboratory characteristics of donors with thalassemia minor in living donor kidney transplant: a case series
por: Nhan Hieu Dinh, et al.
Publicado: (2021)

ESTIMATiON OF IMMUNOBIOLOGICAL EFFICIENCY OF YAKS SPLEEN AUTOLYSATES ON THE MODEL WiTH AZATHIOPRINE IMMUNOSUPPRESSION
por: S. D. Zhamsaranova, et al.
Publicado: (2012)

State Awards as a Factor of Activation of the Donor Movement in Russia
por: A. V. Chistyakov
Publicado: (2021)

EXPRESSION OF IMMUNOCORRECTIVE EFFECTS OF PHENOTROPIL AT DIFFERENT TERMS OF INDUCED IMMUNOSUPPRESSION
por: M. A. Samotrueva, et al.
Publicado: (2014)

INVESTIGATION OF TADF PROPERTIES OF NOVEL DONOR-ACCEPTOR TYPE PYRAZINE DERIVATIVES
por: irak,Zeynep Turhan, et al.
Publicado: (2019)

IMMUNOSUPPRESSIVE EFFECTS OF ARGININE DEIMINASE FROM STREPTOCOCCUS PYOGENES
por: E. A. Starikova, et al.
Publicado: (2015)

Rescate con Sirolimus por rechazo agudo recurrente y diabetes mellitus en trasplante hepático: Caso clínico pediátrico
por: Roque E,Jorge, et al.
Publicado: (2005)

Instructions for kidney recipients and donors (In English for medical providers and in Arabic for patients and donors)
por: Ziad Arabi, et al.
Publicado: (2020)

Role of interferon - g on the immunosuppression during Toxoplasma gondii infection by Trypanosoma lewisi
por: CHINCHILLA,MISAEL, et al.
Publicado: (2005)

Immunosuppressant flavonoids from Scutellaria baicalensis
por: Nova Syafni, et al.
Publicado: (2021)

Rejection; Our Inner Fear
por: Gamze Vesile COLAK, et al.
Publicado: (2021)

Addition of antifibrotic therapy to immunosuppression in hypersensitivity pneumonitis: A case series
por: Margaret Kypreos, et al.
Publicado: (2021)

Leucoencefalopatía reversible posterior: cuatro casos clínicos
por: Hernández Ch,Marta, et al.
Publicado: (2008)

GENETIC VARIANTS OF HEPATITIS B VIRUS IN PRIMARY DONORS IN ASTANA, KAZAKHSTAN
por: Yu. V. Ostankova, et al.
Publicado: (2017)

FOREIGN AID TO UKRAINE AFTER 2014: VOLUMES, PROJECTS AND DONORS’ MOTIVATION
por: O. V. Shishkina
Publicado: (2018)

EFFECTIVENESS OF IMMUNOSUPPRESSANTS ALONG WITH ACEI/ARBS IN TREATING PROTEINURIA IN PATIENTS WITH SOLITARY KIDNEY POST NEPHRECTOMY
por: Nadeem Azam, et al.
Publicado: (2018)

Increased Levels of sCD30 Have No Impact on the Incidence of Early ABMR and Long-Term Outcome in Intermediate-Risk Renal Transplant Patients With Preformed DSA
por: Thomas Drasch, et al.
Publicado: (2021)

Induction of Immune Tolerance in Islet Transplantation Using Apoptotic Donor Leukocytes
por: Naoya Sato, et al.
Publicado: (2021)

Quality of life of renal transplant donors
por: Sagar Koirala, et al.
Publicado: (2017)

DONOR SITE MORBIDITY OF FIBULAR FLAP
por: Ghazanfar Ali, et al.
Publicado: (2021)

Human kidney organoids model the tacrolimus nephrotoxicity and elucidate the role of autophagy
por: Jin Won Kim, et al.
Publicado: (2021)

Long-Term Results of Kidney Transplantation in the Elderly: Comparison between Different Donor Settings
por: Renana Yemini, et al.
Publicado: (2021)

TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
por: V. A. Kozlov, et al.
Publicado: (2017)

TUNING THE ELECTRONIC, PHOTOPHYSICAL AND CHARGE TRANSFER PROPERTIES OF SMALL D-A MOLECULES BASED ON THIENOPYRAZINE-TERTHIENYLS BY CHANGING THE DONOR FRAGMENT: A DFT STUDY
por: AICHA,YOUSSEF AIT, et al.
Publicado: (2017)

Extended Criteria Donors in Living Kidney Transplantation Including Donor Age, Smoking, Hypertension and BMI
por: Plage H, et al.
Publicado: (2020)

Rapidly progressive interstitial lung disease associated with dermatomyositis—Longitudinal course of anti‐MDA5 antibody titer in two cases
por: Kentaro Awaji, et al.
Publicado: (2021)

Covid-19 Vaccination Options for Immunosuppressed Cancer Patients
por: I Dewa Agung Panji Dwipayana, et al.
Publicado: (2021)

Survival Outcome and Prognostic Factors of Corneal Transplantation: A 15-Year Retrospective Cohort Study at King Chulalongkorn Memorial Hospital
por: Reinprayoon U, et al.
Publicado: (2021)

Nicotine exacerbates tacrolimus-induced renal injury by programmed cell death
por: Yu Ji Jiang, et al.
Publicado: (2021)

Donor-transmitted melanoma after limbal stem cell transplantation
por: Anas Alsara, et al.
Publicado: (2017)

Immunomodulatory effects of selenium‐enriched peptides from soybean in cyclophosphamide‐induced immunosuppressed mice
por: Jian Zhang, et al.
Publicado: (2021)

Early Hypertransaminasemia after Kidney Transplantation: Significance and Evolution According to Donor Type
por: Eulàlia Solà-Porta, et al.
Publicado: (2021)

RISK OF DEVELOPMENT OF HYPERTENSION AFTER DONOR NEPHRECTOMY
por: Khurram Mansoor, et al.
Publicado: (2021)

Manejo del potencial donante cadáver
por: Bugedo,Guillermo, et al.
Publicado: (2014)

Circuitous Path to Live Donor Liver Transplantation from the Coordinator’s Perspective
por: Hui-Ying Lin, et al.
Publicado: (2021)